Treatment of Constant Postnasal Drip and Throat Clearing
Start with a first-generation antihistamine/decongestant combination (such as dexbrompheniramine plus sustained-release pseudoephedrine or azatadine plus sustained-release pseudoephedrine) as first-line therapy, as this is the most effective treatment for upper airway cough syndrome regardless of whether the underlying cause is allergic or non-allergic rhinitis. 1, 2
Initial Diagnostic Approach
Your patient has Upper Airway Cough Syndrome (UACS), the preferred term for what was previously called postnasal drip syndrome, which is the most common cause of chronic cough in adults. 1, 2
Key clinical features to assess:
- Sensation of drainage into the throat, frequent throat clearing, nasal congestion, or nasal discharge 1
- Cobblestone appearance of the posterior pharyngeal wall on examination 2
- Mucoid or mucopurulent secretions in the nasopharynx or oropharynx 1
- Pale or bluish swollen nasal mucosa (suggests allergic rhinitis) versus erythematous inflamed turbinates (suggests perennial allergic or non-allergic rhinitis) 1, 3
Critical pitfall: Approximately 20% of patients have "silent" postnasal drip with no obvious symptoms yet still respond to treatment, so absence of typical findings does not rule out UACS. 1, 2, 4
First-Line Treatment Algorithm
Step 1: Initiate Antihistamine/Decongestant Combination
Start with a first-generation antihistamine/decongestant combination such as:
- Dexbrompheniramine maleate plus sustained-release pseudoephedrine sulfate, OR
- Azatadine maleate plus sustained-release pseudoephedrine sulfate 2, 4
Dosing strategy to minimize side effects:
- Begin with once-daily dosing at bedtime for a few days before increasing to twice-daily therapy to minimize sedation 2, 4
- Most patients improve within days to 2 weeks 2, 4
- For chronic cases, continue treatment for a minimum of 3 weeks 4
Why first-generation antihistamines are superior: Their anticholinergic properties provide additional drying effects that newer non-sedating antihistamines lack, making them more effective for both allergic and non-allergic causes. 2, 4
Important contraindication: Newer-generation antihistamines (cetirizine, fexofenadine, loratadine) are ineffective for non-allergic UACS and should not be used as monotherapy. 2, 4
Step 2: Add Intranasal Corticosteroid if Inadequate Response After 1-2 Weeks
If symptoms persist after 1-2 weeks of antihistamine/decongestant therapy:
- Add fluticasone 100-200 mcg daily (or equivalent: triamcinolone, budesonide, mometasone) 2, 3
- Continue for a full 1-month trial 1, 2, 4
- Intranasal corticosteroids are effective for both allergic and non-allergic rhinitis-related UACS 2
Step 3: Alternative for Patients with Contraindications to Decongestants
For patients with hypertension, tachycardia, glaucoma, urinary retention, or other contraindications to oral decongestants:
- Use ipratropium bromide nasal spray as an alternative to provide anticholinergic drying effects without systemic cardiovascular side effects 2, 4
- Can be combined with intranasal corticosteroids 2
Monitoring and Side Effects
Common side effects to counsel patients about:
Serious side effects requiring monitoring:
- Insomnia, urinary retention, jitteriness, tachycardia 2, 4
- Worsening hypertension (monitor blood pressure after initiating decongestants) 2
- Increased intraocular pressure in glaucoma patients 2, 4
When to Consider Alternative Diagnoses
If symptoms persist despite 2 weeks of adequate upper airway treatment with antihistamine/decongestant plus intranasal corticosteroid:
- Evaluate for asthma or non-asthmatic eosinophilic bronchitis 2
- Consider gastroesophageal reflux disease (GERD), which can mimic postnasal drip and cause similar throat clearing symptoms 1, 2, 4
- If GERD is suspected, initiate omeprazole 20-40 mg twice daily before meals for at least 8 weeks plus dietary modifications 2
Special Considerations for Allergic Rhinitis
If history suggests allergic triggers (seasonal symptoms, exposure to specific allergens like animals, family history of atopy):
- Consider allergy testing (skin or blood IgE testing) if diagnosis is uncertain or patient doesn't respond to empiric treatment 1
- Oral leukotriene inhibitors can be added to decrease symptoms of allergic rhinitis 2, 4
- Allergen avoidance strategies should be implemented 4, 3
Critical Pitfalls to Avoid
- Never use topical nasal decongestants for more than 3-5 consecutive days due to risk of rhinitis medicamentosa (rebound congestion) 4
- Do not assume symptoms and physical findings alone establish the diagnosis—successful response to treatment is the gold standard for confirming UACS 1, 4
- Do not overlook "silent" postnasal drip in patients without obvious nasal symptoms 1, 2, 4
- Recognize that GERD can be confused with postnasal drip, as both cause throat clearing and sensation of drainage 1, 2, 4